Literature DB >> 29698105

Radioiodine Treatment of Well-Differentiated Thyroid Cancer: Balancing Risks and Benefits.

Bennett S Greenspan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29698105     DOI： 10.1200/JCO.2018.78.6384

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  [Current controversies in risk-adapted therapy in differentiated thyroid cancer: Is less (therapy) really more?]

Authors:  Amir Kurtaran; Brigitta Schmoll-Hauer; Christina Tugendsam
Journal:  Wien Med Wochenschr       Date:  2019-12-03

2.  Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients.

Authors:  Xiaoran Mei; Xiaoqin Yao; Fang Feng; Weiwei Cheng; Hui Wang
Journal:  BMC Cancer       Date:  2021-05-13       Impact factor: 4.430

3.  The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2.

Authors:  Chao Ding; Tiefeng Shi; Gang Wu; Jianting Man; Hongyu Han; Yunfu Cui
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

4.  Retrospective study of the influence of hypothyroidism on liver function before radioiodine therapy in China: a comparison analysis based on patients with differentiated thyroid cancer.

Authors:  Yanhui Ji; Wei Zheng; Zhaowei Meng; Cailan Wu; Jian Tan; Renfei Wang
Journal:  BMJ Open       Date:  2022-01-18       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.